cladribine has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aran, KR; Gupta, GD; Singh, S | 1 |
| Araki, W; Dey, D; Hayes, CD; Lakshmana, MK; Palavicini, JP; Wang, H | 1 |
2 other study(ies) available for cladribine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Cladribine induces apoptosis, neuroinflammation, mitochondrial oxidative stress, tau phosphorylation and Aβ (1-42) pathway in the hippocampus: An in vivo approach.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cladribine; Disease Models, Animal; Hippocampus; Humans; Neuroinflammatory Diseases; NF-kappa B; Oxidative Stress; Phosphorylation; Rats; tau Proteins | 2023 |
Chronic cladribine administration increases amyloid beta peptide generation and plaque burden in mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cell Line, Tumor; Cell Survival; CHO Cells; Cladribine; Cricetinae; Cricetulus; Culture Media, Conditioned; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Immunoblotting; Immunosuppressive Agents; Maze Learning; Mice; Mice, Transgenic; NIMA-Interacting Peptidylprolyl Isomerase; Peptide Fragments; Peptidylprolyl Isomerase; Plaque, Amyloid | 2012 |